1. Molecular mechanisms of hypoxia in cancer
   Amarnath Challapalli et al, 2017, Clinical and Translational Imaging CrossRef
2. Endothelial cell-specific reduction of heparan sulfate suppresses glioma growth in mice
   Takamasa Kinoshita et al, 2021, Discover Oncology CrossRef
3. In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma
   Andrea Hawkins-Daarud et al, 2015, Journal of The Royal Society Interface CrossRef
4. Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT
   Chowdhury Nusrat Fatema et al, 2014, BMC Cancer CrossRef
5. Positron emission tomography to assess hypoxia and perfusion in lung cancer
   Eline E Verwer, 2014, World Journal of Clinical Oncology CrossRef
6. Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer
   Anna G. Sorace et al, 2017, Molecular Imaging and Biology CrossRef
7. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor
   Takuya Toyonaga et al, 2017, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
8. Overview of Positron-Emission Tomography Tracers for Metabolic Imaging
   Ephraim Parent et al, 2018, Imaging and Metabolism CrossRef
9. High-uptake areas on positron emission tomography with the hypoxic radiotracer 18F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia
   Takaaki Beppu et al, 2015, Annals of Nuclear Medicine CrossRef
10. Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer
    Markus Kroenke et al, 2019, PLOS ONE CrossRef
11. Evaluation of [18F]FDG/[18F]FLT/[18F]FMISO-based micro-positron emission tomography in detection of liver metastasis in human colorectal cancer
    Hao Jiang et al, 2019, Nuclear Medicine and Biology CrossRef
12. Tumour hypoxia: lessons learnt from preclinical imaging
    Isabella Raccagni et al, 2017, Clinical and Translational Imaging CrossRef
13. Tumor hypoxia: a new PET imaging biomarker in clinical oncology
    Nagara Tamaki et al, 2016, International Journal of Clinical Oncology CrossRef
14. The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy
    Shozo Okamoto et al, 2016, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
15. Dual-Tracer Assessment of Dynamic Changes in Reoxygenation and Proliferation Decrease During Fractionated Radiotherapy in Murine Tumors
    Wenjing Yu et al, 2020, Frontiers in Oncology CrossRef
16. Hypoxia Imaging in Gliomas With 18F-Fluoromisonidazole PET: Toward Clinical Translation
    Christopher Bell et al, 2015, Seminars in Nuclear Medicine CrossRef
17. 18 F-Fluoromisonidazole positron emission tomography (FMISO-PET) may reflect hypoxia and cell proliferation activity in oral squamous cell carcinoma
    Jun Sato et al, 2017, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef